| About Cialis |  |
Cialis Mechanism | |
Cialis Benefits | |
Cialis Effects |
|
|
http://www.buy-cialis-online-now.com | |||||||
|
|
||||||||
|
|
||||||||
Date:22nd April 2008 Due to a tremendous swell in the sales of various medicines owned by Eli Lilly, including the anti-impotency medication Cialis, the drug to treat depression Cymbalta (duloxetine) and various other medicines, Eli Lilly’s group revenues have undergone an increase of 14% to $4.81 billion but altogether it is observed that despite this sales boost, the share value of Eli Lilly has remained $49.59. However, statistics related to Cialis and Cymbalta sales point out that the sales of the anti-impotency medication Cialis (tadalafil) has totaled $336.9 million, an increase of 27% and Cymbalta (duloxetine) sales has undergone 37% increase to reach $605.1 million. Sales statistics of Eli Lilly’s other drugs disclose the startling sales increase of cancer drugs Gemzar (gemcitabine) and Alimta (pemetrexed) as well as of specific insulin products Humalog and Humulin. Sources reveal that sales of Gemzar (gemcitabine), has increased by 13% to reach $426.2 million while the other cancer drug Alimta (pemetrexed) has undergone a 32% sales increase to total $247.2 million. Altogether Humalog and Humulin are reported to have undergone 18% and 14% increase in sales respectively and with that the total sales of the drugs have reached the mark of $407.4 million and $257.7 million.Source: http://www.pharmatimes.com/ |
 |
| Home | Sitemap | Contact | Disclaimer | Resources © 2005-06 http://www.buy-cialis-online-now.com All rights reserved. Cialis is the Registered Trademark of Lilly ICOS. |
